$5.02 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 132 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 33.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $375,990,000 | +43.4% | 19,341,024 | 0.0% | 7.48% | +38.4% | ||
| GLAUKOS CORPnote 2.750% 6/1 | $355,849,000 | +9.7% | 271,752,000 | 0.0% | 7.08% | +5.8% | ||
| Buy | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $170,826,000 | +28.4% | 174,372,000 | +10.8% | 3.40% | +23.9% | |
| INVITAE CORPnote 2.000% 9/0 | $162,218,000 | -0.5% | 206,873,000 | 0.0% | 3.23% | -4.0% | ||
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $160,665,000 | -18.1% | 1,512,714 | -24.8% | 3.20% | -21.0% |
| AHCO | Sell | ADAPTHEALTH CORP | $154,438,000 | -23.2% | 8,223,536 | -26.3% | 3.07% | -25.9% |
| New | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $148,264,000 | – | 88,657,000 | +100.0% | 2.95% | – | |
| IONIS PHARMACEUTICALS INCnote 4/0 | $128,518,000 | +9.9% | 127,800,000 | 0.0% | 2.56% | +6.0% | ||
| TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $115,533,000 | +18.9% | 144,516,000 | 0.0% | 2.30% | +14.8% | ||
| SILK | Sell | SILK RD MED INC | $114,092,000 | +17.1% | 2,535,369 | -5.3% | 2.27% | +13.0% |
| CMAX | CAREMAX INC | $112,455,000 | +95.3% | 15,861,090 | 0.0% | 2.24% | +88.4% | |
| APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $99,115,000 | +29.6% | 51,885,000 | 0.0% | 1.97% | +25.1% | ||
| GILD | Sell | GILEAD SCIENCES INC | $94,851,000 | -1.2% | 1,537,539 | -1.0% | 1.89% | -4.6% |
| NUVASIVE INCnote 1.000% 6/0 | $93,716,000 | +0.1% | 96,966,000 | 0.0% | 1.86% | -3.4% | ||
| VTRS | Sell | VIATRIS INC | $90,940,000 | -58.0% | 10,673,700 | -48.4% | 1.81% | -59.5% |
| BIIB | New | BIOGEN INC | $88,110,000 | – | 330,000 | +100.0% | 1.75% | – |
| New | ALPHATEC HLDGS INCnote 0.750% 8/0 | $81,430,000 | – | 100,000,000 | +100.0% | 1.62% | – | |
| New | INTERCEPT PHARMACEUTICALS INnote 3.500% 2/1 | $81,098,000 | – | 78,500,000 | +100.0% | 1.61% | – | |
| PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $80,771,000 | -4.9% | 81,600,000 | 0.0% | 1.61% | -8.2% | ||
| Buy | ACCOLADE INCnote 0.500% 4/0 | $79,078,000 | +33.7% | 105,000,000 | +13.4% | 1.57% | +29.0% | |
| ISEE | Sell | IVERIC BIO INC | $76,139,000 | +51.8% | 4,244,098 | -18.6% | 1.52% | +46.5% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $73,456,000 | +108.6% | 4,855,005 | +3.4% | 1.46% | +101.4% |
| INSMED INCnote 1.750% 1/1 | $73,212,000 | +3.9% | 75,000,000 | 0.0% | 1.46% | +0.3% | ||
| IMGN | Sell | IMMUNOGEN INC | $65,678,000 | -2.8% | 13,740,205 | -8.5% | 1.31% | -6.2% |
| GUARDANT HEALTH INCnote 11/1 | $65,033,000 | +14.7% | 89,036,000 | 0.0% | 1.30% | +10.8% | ||
| CPRX | New | CATALYST PHARMACEUTICALS INC | $62,816,000 | – | 4,896,000 | +100.0% | 1.25% | – |
| LUNG | Buy | PULMONX CORP | $61,990,000 | +21.5% | 3,720,901 | +7.4% | 1.23% | +17.3% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $57,022,000 | +228.1% | 2,891,587 | +224.3% | 1.14% | +217.0% |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $56,098,000 | -0.1% | 57,791,000 | 0.0% | 1.12% | -3.5% | ||
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $54,212,000 | +374.4% | 16,941,357 | +190.6% | 1.08% | +357.2% |
| OAK STR HEALTH INCnote 3/1 | $52,497,000 | +8.1% | 68,000,000 | 0.0% | 1.04% | +4.4% | ||
| Sell | NATERA INCnote 2.250% 5/0 | $51,398,000 | -54.1% | 37,638,000 | -58.5% | 1.02% | -55.7% | |
| MRUS | Buy | MERUS N V | $50,507,000 | +12.3% | 2,521,553 | +27.0% | 1.00% | +8.4% |
| New | NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $48,669,000 | – | 57,604,000 | +100.0% | 0.97% | – | |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $46,093,000 | -43.9% | 2,491,490 | -60.1% | 0.92% | -45.8% |
| Buy | HILLEVAX INC | $45,344,000 | +58.5% | 2,653,231 | +1.3% | 0.90% | +53.1% | |
| COGT | Sell | COGENT BIOSCIENCES INC | $44,258,000 | -16.5% | 2,966,345 | -49.5% | 0.88% | -19.4% |
| EOLS | Buy | EVOLUS INC | $43,390,000 | +3.0% | 5,390,103 | +48.4% | 0.86% | -0.6% |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $42,699,000 | -32.4% | 2,032,335 | -37.4% | 0.85% | -34.7% |
| LIVONGO HEALTH INCnote 0.875% 6/0 | $41,977,000 | -1.0% | 50,000,000 | 0.0% | 0.84% | -4.3% | ||
| Sell | NEVRO CORPnote 2.750% 4/0 | $39,609,000 | -31.4% | 42,000,000 | -31.1% | 0.79% | -33.8% | |
| Sell | 1LIFE HEALTHCARE INCnote 3.000% 6/1 | $39,377,000 | -2.1% | 40,599,000 | -16.5% | 0.78% | -5.5% | |
| CYTK | Sell | CYTOKINETICS INC | $39,395,000 | -13.6% | 813,112 | -29.9% | 0.78% | -16.6% |
| EWTX | EDGEWISE THERAPEUTICS INC | $38,702,000 | +23.6% | 3,933,137 | 0.0% | 0.77% | +19.2% | |
| PTC THERAPEUTICS INCnote 1.500% 9/1 | $37,558,000 | +12.3% | 32,000,000 | 0.0% | 0.75% | +8.4% | ||
| ANAB | Buy | ANAPTYSBIO INC | $37,413,000 | +138.7% | 1,466,600 | +90.0% | 0.74% | +130.7% |
| BKD | Buy | BROOKDALE SR LIVING INC | $37,117,000 | -4.9% | 8,692,561 | +1.2% | 0.74% | -8.2% |
| CNC | Sell | CENTENE CORP DEL | $36,104,000 | -26.3% | 464,000 | -19.8% | 0.72% | -28.8% |
| AMED | Buy | AMEDISYS INC | $34,822,000 | +66.5% | 359,765 | +80.8% | 0.69% | +60.8% |
| PHR | Buy | PHREESIA INC | $34,602,000 | +61.4% | 1,358,000 | +58.4% | 0.69% | +55.9% |
| BLU | Buy | BELLUS HEALTH INC NEW | $32,535,000 | +42.4% | 3,081,000 | +24.6% | 0.65% | +37.6% |
| KURA | Sell | KURA ONCOLOGY INC | $30,313,000 | -37.0% | 2,219,128 | -15.5% | 0.60% | -39.3% |
| PHAT | New | PHATHOM PHARMACEUTICALS INC | $26,757,000 | – | 2,414,897 | +100.0% | 0.53% | – |
| IDYA | New | IDEAYA BIOSCIENCES INC | $26,015,000 | – | 1,743,628 | +100.0% | 0.52% | – |
| VERV | New | VERVE THERAPEUTICS INC | $25,763,000 | – | 750,000 | +100.0% | 0.51% | – |
| Buy | HEALTH CATALYST INCnote 2.500% 4/1 | $25,533,000 | +89.8% | 30,000,000 | +100.0% | 0.51% | +83.4% | |
| MOH | Sell | MOLINA HEALTHCARE INC | $24,738,000 | -47.0% | 75,000 | -55.1% | 0.49% | -48.9% |
| NOVAVAX INCnote 3.750% 2/0 | $24,388,000 | -1.9% | 25,000,000 | 0.0% | 0.48% | -5.5% | ||
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $23,309,000 | – | 816,994 | +100.0% | 0.46% | – |
| TARS | TARSUS PHARMACEUTICALS INC | $22,671,000 | +17.3% | 1,324,214 | 0.0% | 0.45% | +13.0% | |
| ATEC | Buy | ALPHATEC HLDGS INC | $22,137,000 | +39.8% | 2,532,792 | +4.6% | 0.44% | +34.9% |
| INSM | INSMED INC | $20,689,000 | +9.2% | 960,484 | 0.0% | 0.41% | +5.4% | |
| DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $20,671,000 | -67.1% | 1,032,000 | -70.6% | 0.41% | -68.3% |
| New | ENHABIT INC | $20,418,000 | – | 1,454,279 | +100.0% | 0.41% | – | |
| New | VIGIL NEUROSCIENCE INC | $17,951,000 | – | 2,054,794 | +100.0% | 0.36% | – | |
| ISEE | New | IVERIC BIO INCcall | $17,940,000 | – | 1,000,000 | +100.0% | 0.36% | – |
| OMIC | Buy | SINGULAR GENOMICS SYSTEMS IN | $17,695,000 | -26.9% | 7,078,019 | +11.7% | 0.35% | -29.5% |
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $17,384,000 | -1.3% | 18,000,000 | 0.0% | 0.35% | -4.7% | ||
| TGTX | TG THERAPEUTICS INC | $15,851,000 | +39.3% | 2,677,500 | 0.0% | 0.32% | +34.5% | |
| DA32 LIFE SCNCE TEC ACQSTN C | $15,568,000 | +0.4% | 1,600,000 | 0.0% | 0.31% | -3.1% | ||
| Sell | THE ONCOLOGY INSTITUTE INC | $15,557,000 | -9.1% | 3,360,052 | -0.7% | 0.31% | -12.2% | |
| PCRX | PACIRA BIOSCIENCES INC | $15,531,000 | -8.8% | 292,000 | 0.0% | 0.31% | -12.0% | |
| Sell | SEMA4 HOLDINGS CORP | $14,894,000 | -37.3% | 16,973,488 | -9.9% | 0.30% | -39.6% | |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $13,885,000 | – | 870,000 | +100.0% | 0.28% | – |
| AN2 THERAPEUTICS INC | $12,453,000 | +124.3% | 716,538 | 0.0% | 0.25% | +115.7% | ||
| KRYS | New | KRYSTAL BIOTECH INC | $12,198,000 | – | 175,000 | +100.0% | 0.24% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $11,732,000 | – | 2,021,000 | +100.0% | 0.23% | – |
| ADCT | New | ADC THERAPEUTICS SA | $11,521,000 | – | 2,390,297 | +100.0% | 0.23% | – |
| VCEL | New | VERICEL CORP | $11,251,000 | – | 484,947 | +100.0% | 0.22% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $10,955,000 | – | 1,860,000 | +100.0% | 0.22% | – |
| ALEC | ALECTOR INC | $9,982,000 | -6.9% | 1,055,192 | 0.0% | 0.20% | -10.0% | |
| EUCR | EUCRATES BIOMEDICAL ACQUISIT | $10,020,000 | +1.2% | 999,999 | 0.0% | 0.20% | -2.5% | |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $10,000,000 | +1.1% | 999,999 | 0.0% | 0.20% | -2.5% | |
| MTAC | MEDTECH ACQUISITION CORP | $9,930,000 | +0.9% | 999,999 | 0.0% | 0.20% | -2.5% | |
| SNRH | SENIOR CONNECT ACQUISITN COR | $9,945,000 | +1.1% | 1,000,000 | 0.0% | 0.20% | -2.5% | |
| REVH | REVOLUTION HEALTHCAR AQ CORP | $9,820,000 | +0.5% | 1,000,000 | 0.0% | 0.20% | -3.5% | |
| APEN | APOLLO ENDOSURGERY INC | $9,643,000 | +51.0% | 1,750,000 | 0.0% | 0.19% | +45.5% | |
| PHVS | Sell | PHARVARIS N V | $8,472,000 | -67.8% | 1,104,552 | -7.2% | 0.17% | -68.9% |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $7,730,000 | – | 1,000,000 | +100.0% | 0.15% | – |
| TMPM | TURMERIC ACQUISITION CORPcl a | $7,500,000 | +0.7% | 750,000 | 0.0% | 0.15% | -3.2% | |
| IGNY | IGNYTE ACQUISITION CORP | $7,236,000 | +1.2% | 725,000 | 0.0% | 0.14% | -2.0% | |
| Sell | PEPGEN INC | $6,767,000 | -28.5% | 745,293 | -21.8% | 0.14% | -30.8% | |
| FHTX | FOGHORN THERAPEUTICS INC | $6,671,000 | -36.9% | 777,525 | 0.0% | 0.13% | -39.0% | |
| INZY | Sell | INOZYME PHARMA INC | $5,602,000 | -56.4% | 2,090,436 | -22.5% | 0.11% | -57.7% |
| NEOGENOMICS INCnote 1.250% 5/0 | $5,571,000 | +2.4% | 6,500,000 | 0.0% | 0.11% | -0.9% | ||
| GRAY | GRAYBUG VISION INC | $4,967,000 | -13.7% | 5,281,713 | 0.0% | 0.10% | -16.8% | |
| OHPA | ORION ACQUISITION CORP | $4,923,000 | +0.5% | 500,000 | 0.0% | 0.10% | -3.0% | |
| HOWL | WEREWOLF THERAPEUTICS INC | $4,321,000 | +10.3% | 958,125 | 0.0% | 0.09% | +6.2% | |
| QSI | QUANTUM SI INC | $3,850,000 | +18.5% | 1,400,000 | 0.0% | 0.08% | +14.9% | |
| ANNX | ANNEXON INC | $3,609,000 | +64.0% | 583,913 | 0.0% | 0.07% | +60.0% | |
| ORTX | ORCHARD THERAPEUTICS PLCspon ads | $3,475,000 | -14.4% | 6,949,416 | 0.0% | 0.07% | -17.9% | |
| PROF | Sell | PROFOUND MED CORP | $2,959,000 | -76.3% | 732,543 | -57.3% | 0.06% | -77.1% |
| KNTE | KINNATE BIOPHARMA INC | $2,988,000 | -5.2% | 250,000 | 0.0% | 0.06% | -9.2% | |
| NYXOAH S A | $2,868,000 | -31.5% | 455,262 | 0.0% | 0.06% | -33.7% | ||
| ONCR | ONCORUS INC | $2,677,000 | -32.5% | 3,148,977 | 0.0% | 0.05% | -35.4% | |
| AFIB | Buy | ACUTUS MED INC | $2,333,000 | -21.3% | 2,651,667 | +0.1% | 0.05% | -24.6% |
| DCTH | Sell | DELCATH SYS INC | $1,555,000 | -22.1% | 486,068 | -2.8% | 0.03% | -24.4% |
| CMAXW | CAREMAX INC*w exp 06/08/202 | $1,263,000 | +161.0% | 672,000 | 0.0% | 0.02% | +150.0% | |
| THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $691,000 | +10.6% | 1,250,000 | 0.0% | 0.01% | +7.7% | ||
| MDVL | MEDAVAIL HOLDINGS INC | $649,000 | -49.3% | 836,626 | 0.0% | 0.01% | -50.0% | |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $616,000 | +108.1% | 733,333 | 0.0% | 0.01% | +100.0% | |
| NUVB | New | NUVATION BIO INC | $550,000 | – | 245,360 | +100.0% | 0.01% | – |
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $390,000 | -35.0% | 1,000,000 | 0.0% | 0.01% | -33.3% | ||
| CABA | CABALETTA BIO INC | $302,000 | -38.6% | 464,252 | 0.0% | 0.01% | -40.0% | |
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $177,000 | -5.9% | 333,333 | 0.0% | 0.00% | 0.0% | |
| IGNYW | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $45,000 | -40.8% | 362,500 | 0.0% | 0.00% | -50.0% | |
| SURROZEN INC*w exp 08/01/203 | $31,000 | -3.1% | 166,666 | 0.0% | 0.00% | 0.0% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $33,000 | -29.8% | 166,666 | 0.0% | 0.00% | 0.0% | |
| SOMALOGIC INC*w exp 08/31/202 | $53,000 | -41.8% | 120,000 | 0.0% | 0.00% | -50.0% | ||
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | 1 | 0.0% | 0.00% | – | |
| MTACU | MEDTECH ACQUISITION CORPunit 12/18/2025 | $0 | – | 1 | 0.0% | 0.00% | – | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $7,000 | -63.2% | 250,000 | 0.0% | 0.00% | – | |
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $7,000 | -36.4% | 125,000 | 0.0% | 0.00% | – | |
| GKOS | Sell | GLAUKOS CORP | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| WINT | WINDTREE THERAPEUTICS INC | $6,000 | -25.0% | 20,148 | 0.0% | 0.00% | – | |
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $10,000 | -71.4% | 500,000 | 0.0% | 0.00% | -100.0% | |
| REVHW | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $9,000 | -81.6% | 200,000 | 0.0% | 0.00% | -100.0% | |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | 1 | 0.0% | 0.00% | – | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $13,000 | -40.9% | 333,333 | 0.0% | 0.00% | – | |
| MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $20,000 | -28.6% | 333,333 | 0.0% | 0.00% | -100.0% | |
| SRSAW | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $7,000 | -78.8% | 333,333 | 0.0% | 0.00% | -100.0% | |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -291,005 | -100.0% | -0.02% | – |
| ETNB | Exit | 89BIO INC | $0 | – | -506,100 | -100.0% | -0.03% | – |
| Exit | BENEFITFOCUS INCnote 1.250%12/1 | $0 | – | -6,500,000 | -100.0% | -0.12% | – | |
| OM | Exit | OUTSET MED INC | $0 | – | -400,622 | -100.0% | -0.12% | – |
| Exit | XILIO THERAPEUTICS INC | $0 | – | -2,078,692 | -100.0% | -0.12% | – | |
| NKTX | Exit | NKARTA INC | $0 | – | -600,000 | -100.0% | -0.15% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -1,419,000 | -100.0% | -0.24% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -1,111,111 | -100.0% | -0.44% | – |
| ORGO | Exit | ORGANOGENESIS HLDGS INC | $0 | – | -4,447,740 | -100.0% | -0.45% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -313,000 | -100.0% | -0.52% | – |
| Exit | PTC THERAPEUTICS INCnote 3.000% 8/1 | $0 | – | -25,417,000 | -100.0% | -0.53% | – | |
| Exit | DYNAVAX TECHNOLOGIES CORPnote 2.500% 5/1 | $0 | – | -30,000,000 | -100.0% | -0.92% | – | |
| Exit | INSULET CORPnote 0.375% 9/0 | $0 | – | -57,581,000 | -100.0% | -1.36% | – | |
| Exit | NUVASIVE INCnote 0.375% 3/1 | $0 | – | -80,000,000 | -100.0% | -1.48% | – | |
| Exit | ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $0 | – | -52,500,000 | -100.0% | -2.07% | – | |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -500,000 | -100.0% | -2.10% | – |
| Exit | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $0 | – | -88,657,000 | -100.0% | -2.30% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.